Published in
Elsevier, European Journal of Cancer, (175), p. 110-119, 2022
DOI: 10.1016/j.ejca.2022.08.002
Links
Tools
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
Journal article published in 2022 by
Miguel A. Climent,
Albert Font,
Ignacio Durán,
Javier Puente,
María José Méndez-Vidal,
María Isabel Sáez,
Carmen Santander Lobera,
Jóse Ángel Arranz Arija,
Aranzazu González-Del-Alba 
,
Alfredo Sánchez-Hernandez ,
Maria Jose Juan Fita,
Emilio Esteban ,
Teresa Alonso-Gordoa,
Begoña Mellado Gonzalez,
Pablo Maroto
and other authors.
,
Alfredo Sánchez-Hernandez ,
Maria Jose Juan Fita,
Emilio Esteban ,
Teresa Alonso-Gordoa,
Begoña Mellado Gonzalez,
Pablo Maroto
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 